Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P McEvoy

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Comprehensive Psychiatry|July 1, 1986
The neuroleptic threshold as a marker of minimum effective neuroleptic doseJ P McEvoy
The Journal of Clinical Psychiatry|December 1, 1986
Neuroleptic dose and the need for prophylactic anticholinergic drugsJ P McEvoy
Annals of Internal Medicine|August 1, 1981
Organic brain syndromesJ P McEvoy
Hospital & Community Psychiatry|April 1, 1992
Patients' rightsJ P McEvoy
Southern Medical Journal|November 1, 1978
Psychiatric consultationsJ P McEvoy
The American Journal of Psychiatry|January 1, 1981
Organic brain syndromes in DSM-IIIJ P McEvoy
The American Journal of Psychiatry|November 1, 1986
Rapid shifts in therapeutic and extrapyramidal effects of neurolepticsJ P McEvoy
The Journal of Clinical Psychiatry|September 1, 1987
A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory functionJ P McEvoy
The Journal of Clinical Psychiatry|May 1, 1994
Efficacy of risperidone on positive features of schizophreniaJ P McEvoy
Journal of Clinical Psychopharmacology|October 1, 1983
The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugsJ P McEvoy
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Comprehensive Psychiatry|July 1, 1986
The neuroleptic threshold as a marker of minimum effective neuroleptic doseJ P McEvoy
The Journal of Clinical Psychiatry|December 1, 1986
Neuroleptic dose and the need for prophylactic anticholinergic drugsJ P McEvoy
Annals of Internal Medicine|August 1, 1981
Organic brain syndromesJ P McEvoy
Hospital & Community Psychiatry|April 1, 1992
Patients' rightsJ P McEvoy
Southern Medical Journal|November 1, 1978
Psychiatric consultationsJ P McEvoy
The American Journal of Psychiatry|January 1, 1981
Organic brain syndromes in DSM-IIIJ P McEvoy
The American Journal of Psychiatry|November 1, 1986
Rapid shifts in therapeutic and extrapyramidal effects of neurolepticsJ P McEvoy
The Journal of Clinical Psychiatry|September 1, 1987
A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory functionJ P McEvoy
The Journal of Clinical Psychiatry|May 1, 1994
Efficacy of risperidone on positive features of schizophreniaJ P McEvoy
Journal of Clinical Psychopharmacology|October 1, 1983
The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugsJ P McEvoy
Pageof 8